ANIX - Anixa Biosciences • Financials

Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.

Complete and updated financials table with all primary indicators: Net Income, Revenue, EBITDA, Margin, ROE, Dividends

Year	Revenue	EBITDA	Net Inc	Net Mrg	EPS	Equity	ROE	Net Debt Aj	ND/EBITDA Aj	OCF Aj	Capex	FCF	Free Aj	Buyback	Dividend	Payout	DY
10/2016	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
10/2017	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
10/2018	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
10/2019	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
10/2020	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
10/2021	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
10/2022	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
10/2023	0	-11	-	L	L	24	L	-24	-	-11	0	0	-11	0	0	-	-
10/2024	0	-14	-	0%	L	20	L	-20	-	-12	0	3	-12	-0	0	-	-
10/2025	0	-12	-	0%	L	15	L	-15	-	-11	0	2	-11	0	0	-	-

To see all financials—including updated, you must be Premium.